BlackRock Investment Management, LLC - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 45 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2016$619,000
-9.6%
47,2370.0%0.00%0.0%
Q3 2016$685,000
+23.2%
47,237
+1.8%
0.00%0.0%
Q2 2016$556,000
-14.3%
46,413
+33.3%
0.00%0.0%
Q1 2016$649,000
-11.2%
34,820
+2.4%
0.00%0.0%
Q4 2015$731,000
+27.1%
34,011
+0.2%
0.00%0.0%
Q3 2015$575,000
-55.8%
33,938
-2.3%
0.00%
-50.0%
Q2 2015$1,302,00034,7220.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2015
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders